Sign in

CIK 0001907108 · <br>Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
854012572
Phone
(212) 547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$43,228
in 3 filings

Net −$43,228. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Tamayo Louis Edward −$20K Chief Financial Officer sold 4% of stake
  2. Townsend Richard Nolan −$17K Chief Executive Officer sold <1% of stake
  3. Otero Jose Manuel −$6K Chief Operating Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-25 Van Hauwermeiren Timothy Director Grant or award · Stock Option (right to buy) +35,000 35,000
2026-06-25 Agger Mette Kirstine Director Grant or award · Stock Option (right to buy) +35,000 35,000
2026-06-25 Altschuler Steven Director Grant or award · Stock Option (right to buy) +35,000 35,000
2026-06-25 DIAZ REINALDO M Director Grant or award · Stock Option (right to buy) +35,000 35,000
2026-06-25 CHOLMONDELEY PAULA H Director Grant or award · Stock Option (right to buy) +35,000 35,000
2026-05-18 Otero Jose Manuel Chief Operating Officer Sale −1,302 $5.07 $7K 130,088
2026-05-18 Townsend Richard Nolan Chief Executive Officer Sale −3,342 $5.06 $17K 336,764
2026-04-28 Sepp-Lorenzino Laura Director Grant or award · Stock Option (right to buy) +50,000 50,000
2026-04-06 Townsend Richard Nolan Chief Executive Officer Sale 10b5-1 −55,000 $5.69 $313K 340,106
2026-03-13 Otero Jose Manuel Chief Operating Officer Grant or award +5,930 $2.64 $16K 131,390
2026-03-13 Townsend Richard Nolan Chief Executive Officer Grant or award +2,623 $2.64 $7K 395,106
2026-02-18 Otero Jose Manuel Chief Operating Officer Sale −3,016 $6.40 $19K 125,460
2026-02-18 Townsend Richard Nolan Chief Executive Officer Sale −10,173 $6.38 $65K 392,483
2026-02-13 Bhalla Narinder Pal Chief Medical Officer Grant or award +49,500 49,500
2026-02-13 Bhalla Narinder Pal Chief Medical Officer Grant or award · Stock Option (right to buy) +297,000 297,000
2026-02-04 Tamayo Louis Edward Chief Financial Officer Grant or award +44,665 89,665
2026-02-04 Tamayo Louis Edward Chief Financial Officer Grant or award · Stock Option (right to buy) +226,665 226,665
2026-02-04 Otero Jose Manuel Chief Operating Officer Grant or award +65,000 128,476
2026-02-04 Otero Jose Manuel Chief Operating Officer Grant or award · Stock Option (right to buy) +260,000 260,000
2026-02-04 Townsend Richard Nolan Chief Executive Officer Grant or award +161,665 402,656

Page 2 of 9 · 165 trades